The management of neovascular age‐related macular degeneration: A systematic literature review of patient‐reported outcomes, patient mental health and caregiver burden-Reference-Cited by-同舟云学术

The management of neovascular age‐related macular degeneration: A systematic literature review of patient‐reported outcomes, patient mental health and caregiver burden

Published:2022-07-05 Issue:1 Volume:101 Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmologica

Author:

Gale Richard P.¹,Finger Robert P.²,Eldem Bora³,Aslam Tariq⁴⁵,Barratt Jane⁶,Daien Vincent⁷,Kodjikian Laurent⁸⁹,Loewenstein Anat¹⁰,Okada Mali¹¹,Wong Tien Yin¹²¹³,Sylvanowicz Michelle¹⁴,Rodríguez Francisco J.¹⁵

Affiliation:

1. York and Scarborough Teaching Hospital NHS Foundation Trust York UK

2. Department of Ophthalmology University of Bonn Bonn Germany

3. Hacettepe University Ankara Turkey

4. Manchester Royal Eye Hospital Manchester UK

5. University of Manchester Manchester UK

6. International Federation on Ageing Toronto ON Canada

7. Department of Ophthalmology University Hospital of Montpellier Montpellier France

8. University of Lyon Lyon France

9. Croix‐Rousse University Hospital Lyon France

10. Tel Aviv Medical Center, Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

11. Royal Victorian Eye and Ear Hospital Melbourne Vic. Australia

12. Singapore National Eye Centre Singapore Eye Research Institute Singapore Singapore

13. Ophthalmology and Visual Sciences Academic Clinical Program, Duke‐NUS Medical School Singapore Singapore

14. Bayer Consumer Care Basel Switzerland

15. Department of Ophthalmology Fundación Oftalmológica Nacional and Universidad del Rosario School of Medicine Bogotá Colombia

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.15201

Reference74 articles.

1. Impact on Visual Acuity in Neovascular Age Related Macular Degeneration (nAMD) in Europe Due to COVID-19 Pandemic Lockdown

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

4. Predictors of health-related quality of life in Chinese patients receiving treatment for neovascular age-related macular degeneration: a prospective longitudinal study

5. Evaluation of quality of life and treatment satisfaction of patients receiving anti‐VEGF therapy;Bobykin E.;Ophthalmic Research,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors affecting quality of life in patients with neovascular age-related macular degeneration;AJO International;2024-10

2. Dual pathway inhibition with faricimab for previously treated neovascular age-related macular degeneration and diabetic macular oedema: guidance from a UK panel of retina specialists;Eye;2024-08-30

3. European Unmet Needs in the Management of Neovascular Age-Related Macular Degeneration in Daily Practice;Ophthalmology Retina;2024-06

4. Depression and Eye Disease—A Narrative Review of Common Underlying Pathophysiological Mechanisms and their Potential Applications;Journal of Clinical Medicine;2024-05-24

5. Association of baseline factors with 1-year outcomes in the SB11-ranibizumab equivalence trial: A post hoc analysis;Asia-Pacific Journal of Ophthalmology;2024-05